BugSpeaks, India’s Pioneering Microbiome Health Platform, expands into Europe with Launch in Bulgaria
BugSpeaks, a well known brand in the microbiome domain, developed by Leucine Rich Bio, today announced a groundbreaking step into the European market with its debut in Bulgaria. The expansion comes through a strategic collaboration with Medico-Dental Center Imperial Palace Ltd., marking BugSpeaks’ inaugural European partnership.
Through this collaboration, Bulgarian consumers will gain access to BugSpeaks’ full suite of advanced microbiome tests, including gut, skin, vaginal, and oral microbiome assessments. Each test uses next-generation sequencing and proprietary analytics to deliver personalized insights into gut and skin health, disease susceptibility, and nutritional recommendations.
Dr. Debojyoti Dhar, Co-founder & Director of Leucine Rich Bio, expressed enthusiasm for the launch:“I am happy to share the launch of BugSpeaks in Bulgaria, marking a significant milestone in bringing India’s pioneering advancements in microbiome science to Europe. BugSpeaks offers a non-invasive, at-home test that provides detailed microbial profiling, personalized nutrition recommendations, and early detection of risks such as diabetes, obesity, and digestive disorders. Users gain actionable insights to optimize well-being and prevent health issues, all backed by cutting-edge science already transforming lives across Asia and beyond.”
This move significantly strengthens BugSpeaks’ global presence, already spanning markets such as Thailand, the Philippines, Brazil, UAE, and Qatar, through trusted partners and distributors. The Bulgaria expansion represents a key milestone furthering the company’s mission to democratize microbiome testing across continents.
Above views are of the author and not of the website kindly read disclaimer
